Current Canadian Experience With Capecitabine
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Oncology(nursing),Oncology
Reference13 articles.
1. Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
2. Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
3. The Role of Capecitabine, an Oral, Enzymatically Activated Fluoropyrimidine, in the Treatment of Metastatic Breast Cancer
4. Fluorouracil and the New Oral Fluorinated Pyrimidines
5. Patient preferences for oral versus intravenous palliative chemotherapy.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer;Medical Oncology;2021-11-23
2. A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD);European Journal of Oncology Nursing;2021-02
3. Capecitabine Induced Hand-Foot Syndrome: A Systematic Review of Case Reports;Clinical and Experimental Health Sciences;2019-06-30
4. Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites;Journal of Pharmacy & Pharmaceutical Sciences;2019-04-09
5. Analysis of data on capecitabine-related adverse drug reactions from the Korean adverse event reporting system database;European Journal of Oncology Nursing;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3